Emergency Medicine Doctors in East Orange, NJ Accepting Medicare

8 Emergency Medicine doctors found. Showing 1 - 8

Dr. James N Ezema, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 300 Central Ave, East Orange, NJ 07018 Phone: 973-266-8400

Dr. Solomon V Alcantara, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 300 Central Ave, East Orange, NJ 07018 Phone: 973-672-8400

Christian Patrick Didonna, PA-C Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Central Ave, East Orange, NJ 07018 Phone: 973-672-8400

Mrs. Caroline T Hodge, P.A. Emergency Medicine - Emergency Medical Services Medicare: Medicare Enrolled Practice Location: 300 Central Ave, East Orange, NJ 07018 Phone: 973-470-3000    Fax: 973-470-3506

Lalitha Krishnan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 300 Central Ave, East Orange, NJ 07018 Phone: 973-672-8400

Henry Daniel Montilla, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 300 Central Ave, East Orange, NJ 07018 Phone: 973-672-8400

Dr. Chinwe H Ogedegbe, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 Central Avenue, East Orange, NJ 07018 Phone: 973-672-8400

Dr. Seymour W Thomas, M.D. Emergency Medicine - Emergency Medical Services Medicare: Not Enrolled in Medicare Practice Location: 300 Central Ave, East Orange, NJ 07018 Phone: 973-470-3000

News Archive

Findings open new perspectives for research on proteins that control metastasis

In experiments on zebrafish, Freiburg researchers have demonstrated that the same proteins that lead to the formation of metastases in humans also cause the cells to migrate during embryonic development.

Researchers confirm safety of cancer-specific PET probe in first-in-human clinical studies

A group of researchers led by Assistant Professor WATABE Tadashi of the Graduate School of Medicine of Osaka University achieved the stable domestic production of automatic synthesis modules for positron emission tomography (PET) probe F-18 NKO-035, a LAT1-selective amino acid derivative radiolabeled with 18F, confirming its safety in first-in-human clinical studies conducted at Osaka University Hospital in November 2019.

Catalent Pharma Solutions, Endotis Pharma forge alliance to develop oral formulations of small-glycol drugs

Catalent Pharma Solutions, the leading provider of advanced oral drug delivery technologies to the pharmaceutical industry, has entered into a strategic alliance with Endotis Pharma for the development of oral formulations of synthetic oligosaccharides.

Canadian Cancer Society, POGO collaborate to improve quality of life in childhood cancer survivors

The Canadian Cancer Society and the Pediatric Oncology Group of Ontario (POGO) today announced that they have joined forces to improve the quality of outcomes for children and adolescents diagnosed with cancer and their families.

Nanotubes destroy kidney tumors

By injecting multiwalled carbon nanotubes (MWCNTs) into tumors and heating them with a quick, 30-second zap of a laser, a multi-institutional team of researchers from the Wake Forest University School of Medicine (WFUSOM), Wake Forest University Center for Nanotechnology and Molecular Materials, Rice University, and Virginia Polytechnic Institute and State University has developed a new type of therapy that effectively kills kidney tumors in nearly 80% of treated mice. Researchers say that the findings, which were published in the Proceedings of the National Academy of Sciences of the United States of America, suggest a potential future cancer treatment for humans.

Read more Medical News

› Verified 3 days ago